NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of ambulatory healthcare and connectivity solutions, today announced the company executed agreements for its NextGen CHS (Community Health Solution) product with five organizations during the last few months. Dozens of healthcare organizations – representing millions of patients currently covered – have now licensed NextGen CHS, a central data repository that enables users to exchange patient data and referrals – using state-of-the-art information security measures – with other community-based healthcare organizations, including hospitals, labs, pharmacies, payers and health information exchanges.

One such organization is Elmhurst Memorial Healthcare (EMHC), an Illinois-based vertically integrated community health system. Elmhurst Clinic, EMHC’s affiliated multi-specialty physician office practice, has utilized NextGen technology since 2004 and will actively participate in the implementation of NextGen CHS across the enterprise.

“With discussions around the stimulus and meaningful use, NextGen CHS can be a key component in not only connecting physicians across our enterprise but across our area,” said Charles Colander, CIO for Elmhurst Memorial Healthcare. “We believe the platform will help facilitate better physician-to-hospital and physician-to-physician communications, and will also streamline and enhance patient care across facilities in our network. Over the long term, this can help us meet meaningful use criteria and qualify for program reimbursements.”

Offering a single-point connection for each participant in a community “hub,” NextGen CHS eliminates the need for organizations to invest in the development of multiple point-to-point interfaces to share discrete clinical data, including lab or test results, ER visits, referrals, medications and allergies. The product enables organizations to exchange this data even if they don’t have an electronic health record (EHR) system, resulting in truer continuity of care and advanced adoption of the “medical home” model.

The referral process is likewise streamlined, making critical data available to all participating community providers – including physicians in the emergency department (ED) – through a single patient record. Specialists, for example, have direct access to current medical records, resulting in faster and better medical decision-making, and the elimination of time spent tracking down information. Reporting and analytic tools help organizations foster disease and wellness management monitoring, as well as quality improvement efforts like P4P.

“Interoperability will continue to play a critical role as the government pushes healthcare organizations toward automation,” said Patrick Cline, president of NextGen Healthcare. “We applaud these market leading organizations for selecting NextGen CHS as their interoperability platform, and look forward to helping them achieve the many operational and clinical benefits associated with data exchange.”

About NextGen Healthcare

NextGen Healthcare Information Systems, Inc. a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), provides integrated electronic health record and practice management systems, connectivity solutions, and billing services for hospitals and ambulatory practices of all sizes and specialties. For more information about NextGen, please visit www.nextgen.com and www.qsii.com.

About Elmhurst Memorial Healthcare

Founded in 1926, Elmhurst Memorial Hospital today is Elmhurst Memorial Healthcare, a comprehensive health system with multiple locations and services designed to enhance the health of the communities and customers we serve. In May 2008, Elmhurst Memorial Healthcare broke ground on a new, integrated healthcare campus on the corner of York and Roosevelt roads in Elmhurst. Opening in fall 2011, the campus will include an all-private-room, state-of-the-art hospital. For more information about Elmhurst Memorial Healthcare, please call CareMatch, our physician referral line, at 630-782-7878, or visit our Web site at www.emhc.org.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems' periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.